Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis

International Journal of Dermatology

Volumn 41, Issue 10, 2002, Pages 670-675

  Bosch, Ricardo J ^a,b   Rodrigo, Ana B ^a   Sánchez, Purificación ^a   De Gálvez, María V ^a   Herrera, Enrique ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIHISTAMINIC AGENT; ANTILEISHMANIAL AGENT; ANTIMONY DERIVATIVE; ANTIPROTOZOAL AGENT; STEROID;

ADULT; BONE MARROW EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CRYPTOCOCCOSIS; DERMATOFIBROMA; FEMALE; HEMANGIOMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA; MALE; NONHUMAN; PREVALENCE; PROTOZOON; PRURITUS; PSORIASIS; REITER SYNDROME; RELAPSE; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION; SUPERINFECTION; VISCERAL LEISHMANIASIS;

ADULT; ANIMALS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 0036773795     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01610.x     Document Type: Conference Paper

References (53)

1. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
2. Ramesh V, Mukherjee A. Post-kala-azar dermal leishmaniasis. Int J Dermatol 1995; 34: 85-91.
3. Albrecht H, Sobottka I, Emminger C, et al. Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonenedemic for leishmania donovani. Arch Pathol Laboratory Med 1996; 120: 189-198.
4. Rosen T. Leishmaniasis and the JEADV. J Eur Acad Dermatol Venereol 1998; 10: 212-213.
5. Echevarria J, Campos P, Chang J, et al. Mucocutaneous leishmaniasis and AIDS. Case report. Trans R Soc Trop Med Hyg 1993; 87: 186.
6. Belaich S, Bouscarat F, Picard C. Leishmaniasis and AIDS. In: Burgdorf WHC, Katz SI, eds. Dermatology Progress and Perspectives. New York: The Partenon Publishing Group 1993, pp. 407-409.
7. Miralles ES, Nunez M, Hilara Y, et al. Mucocutaneous leishmaniasis and HIV. Dermatology 1994; 189: 275-277.
8. Inhof M, Schöfer H, Milbradtr R, Liutz TH. Mucocutaneous leishmaniasis in a European HIV-infected patient. Eur J Dermatol 1995; 5: 594-596.
9. Herrera E, Sánchez Bosch RJ. Disseminated cutaneous leishmaniasis in an HIV-infected patient. Int J STD AIDS 1995; 6: 125-126.
10. Durand I, Beylot-Barry M, Weill FX, et al. Disseminated cutaneous leishmaniasis revealing human immunodeficiency virus infection. Ann Dermatol Venereol 1998; 125: 268-270.
11. Rosatelli JB, Souza CS, Soares FA, et al. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome. J Eur Acad Dermatol Venereol 1998; 10: 229-232.
12. de Souza I, Daibes R, de Guimaraens Farias M, et al. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 1998; 10: 214-217.
13. Mattos M, Caiza A, Fernandes O, et al. American cutaneous leishmaniasis associated with HIV infection: report of four cases. J Eur Acad Dermatol Venereol 1998; 10: 218-225.
14. Alvar J, Gutierrez Solar B, Molina R, et al. Prevalence of Leishmaniasis infection among AIDS patients. Lancet 1992; 339: 1427.
15. Dedet JP, Lambert M, Pratlong F. Leishmaniasis and human immunodeficiency virus infections. Presse Med 1995; 24: 1036-1040.
16. Rosenthal E, Marty P, Pazot-Martin J, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Tras R Soc Trop Med Hyg 1995; 89: 159-162.
17. Agostoni C, Doprigoni N, Malfitano A, et al. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases. Infection 1998; 26: 93-99.
18. Pineda JA, Gallardo JA, Macias J, et al. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol 1998; 36: 2419-2422.
19. World Health Organisation. AIDS, leishmanias dangers of clash highlighted. TDR News 1991; 36: 1.
20. Montalban C, Martinez Fernández R, Calleja JL, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989; 4: 655-660.
21. Rousaud F. Visceral leishmaniasis in patients infected by HIV. An AIDS diagnostic criteria? Rev Clin Esp 1993; 192: 462.
22. Albrecht H. Redefining AIDS: towards a modification of the current AIDS care definition. Clin Infect Dis 1997; 24: 64-74.
23. Yebra M, Segovia J, Montalban C, Vargas JA. Is kala-azar a diagnostic criterion for acquired immunodeficiency syndrome? Med Clin (Barc) 1989; 93: 16.
24. Kubar J, Marty P, Lelivre A, et al. Visceral leishmaniasis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 1998; 12: 2147-2153.
25. Gradoni L, Scalone A, Gramiccia M. HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg 1993; 87: 94-96.
26. Alvar J, Jimenez M. Could infected drug-users be potential Leishmania infantum reservoirs? AIDS 1994; 8: 854.
27. Amela C, Lopez-Gay D, Alberdi JC, Castilla J. Infecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur J Epidemiol 1996; 12: 91-92.
28. Herrera E, Bosch RJ, Fernandez F, et al. The presence and significance of leishmania in mucocutaneous biopsies from HIV+ patients with visceral leishmaniasis. Eur J Dermatol 1996; 6: 501-504.
29. Belda A, Diaz F, Martinez B, et al. Visceral leishmaniasis and AIDS. Report of 2 cases with cutaneous dissemination. Ann Med Interna 1994; 11: 398-400.
30. Romeu J, Milla F, Batlle M, et al. Visceral leishmaniasis involving lung and cutaneous Kaposi's sarcoma lesion. AIDS 1991; 5: 1272.
31. Taillan B, Marty P, Scneider S, et al. Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of the skin. Eur J Med 1992; 4: 255.
32. Gallego MA, Aguilar A, Plaza S, et al. Kaposi's sarcoma with an intense parasitization by Leishmania. Cutis 1996; 57: 103-105.
33. Abajo P, Bueno GF, Fraga J, et al. Leishmaniasis and Kaposi's sarcoma in an HIV-infected patient. Am J Dermatopathol 1997; 19: 101-103.
34. España A, Hermida JM, Mantilla P, Buzón L. Cutaneous and systemic leishmaniasis with herpes virus infection in an AIDS patient [Letter]. Rev Clin Esp 1990; 187: 437.
35. Barrio J, Lecona M, Cosin J, et al. Leishmania infection occurring in herpes zoster lesions in an HIV-positive patient. Br J Dermatol 1996; 134: 164-166.
36. Colebunders R, Depraetere K, Verstraeten Th, et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999; 41: 847-850.
37. Reus S, Sanchez R, Portilla J, et al. Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection. Enferm Infecc Microbiol Clin 1999; 17: 515-520.
38. Cnudde F, Raccurt C, Boulard F, et al. Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Ghadeloupe, West Indies. AIDS 1994; 8: 559-560.
39. Scaglia M, Malfitano A, Douville H, et al. Dermonodular and visceral leishmanoiasis due to Leishmania infantum with a new isoenzyme pattern report of a case involving a patient with AIDS. Clin Infect Dis 1996; 22: 376-377.
40. Rios Buceta L, Buezo GF, Penas PF, et al. Post kala-azar dermal Leishmaniasis in an HIV-patient. Int J Dermatol 1996; 35: 303-304.
41. Ara M, Maillo C, Peon G, et al. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus. Br J Dermatol 1998; 139: 114-117.
42. Villareal M, Yebra M, García M, Salas C. Nodular cutaneous lesions in a patient with human immunodeficiency virus infection. Rev Clin Esp 1998; 198: 469-470.
43. Belda A, Pascual JM, Prats A, García J. Erythroderma as presentation form of visceral leishmaniasis in a patient with human immunodeficiency virus infection. Rev Clin Esp 1992; 191: 454.
44. Dauden E, Penas PF, Rios L, et al. Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS. J Am Acad Dermatol 1996; 35: 316-319.
45. Rubio FA, Robayna G, Herranz P, et al. Leishmaniasis presenting as a psoriasiform eruption in AIDS. Br J Dermatol 1997; 136: 792-794.
46. Michiels JF, Monteil RA, Hofman P, et al. Oral leishmaniasis and Kaposi's sarcoma in an AIDS patient. J Oral Pathol Med 1994; 23: 45-46.
47. Banuls J, Boix V, Portilla J, Silvestre JF. Leishmaniasis as a cause of oral disease in HIV infection. AIDS 1995; 9: 96-98.
48. Vazquez-Pineiro T, Fernandez JM, Gonzalo JC, et al. Visceral leishmaniasis: a lingual presentation in a patient with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 179-182.
49. Perrin C, Taillan B, Hofman P, et al. Atypical cutaneous histological features of visceral leishmaniasis in acquired immunodeficiency syndrome. Am J Dermatopathol 1995; 17: 145-150.
50. Hofman V, Marty P, Perrin C, et al. The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome. Hum Pathol 2000; 31: 75-84.
51. Berhe N, Wolday D, Hailu A, et al. HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS 1999; 13: 1921-1925.
52. Murray HW. Kala-azar as an AIDS-related opportunistic infection. AIDS Patient Care STDS 1999; 13: 459-465.
53. Soriano V, Dona C, Rodriguez-Rosado R, et al. Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly antiretroviral therapy. AIDS 2000; 14: 283-286.